January 3, 2023Open Access

Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our pan-tumor study provides biological insights into the genetic heterogeneity and tissue specificities of multi-PIK3CA mutations, with potential clinical utility to guide PI3K inhibition strategies.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Sivakumar et al. (Tue,) studied this question.

synapsesocial.com/papers/69d98eac0d540cafc583625e https://doi.org/https://doi.org/10.1158/1078-0432.ccr-22-2270

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing2013 · 2,196 citations
2ESR1 ligand-binding domain mutations in hormone-resistant breast cancer2013 · 1,260 citations
3Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast2018 · 65 citations
4A continuum model for tumour suppression2011 · 504 citations
5The present and future of PI3K inhibitors for cancer therapy2021 · 224 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo